Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CYCC | Common Stock | Award | $0 | +15.8K | +666.47% | $0.00 | 18.2K | Jun 14, 2022 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CYCC | Stock Option (right to buy) | Award | $0 | +31.6K | $0.00 | 31.6K | Jun 14, 2022 | Common Stock | 31.6K | $1.11 | Direct | F2 |
Id | Content |
---|---|
F1 | The reporting person received an award of 15,822 restricted stock units on June 14, 2022, which shall vest in full on June 14, 2023. |
F2 | These options were granted to Dr. Spiegel for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc. |